EUVIMEDEUVIMED entdecken
Übersichtsarbeit

From binary senescence to state-resolved senotherapy in cancer: Therapeutic windows from heterogeneity

Ziyu Xu, Jiamin Guo, Zheran Liu, Jiayun Yu, Ruiwan Yuan, Yu Min, Zhigong Wei, Xingchen Peng

Ageing Research Reviews · 2026-10 · 121 · 103270

DOI: 10.1016/j.arr.2026.103270 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-10. Verfasst von Ziyu Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, West China Hospital and State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China; Sichuan Provincial Key Labo…. Hauptthemen laut MEDLINE: Neoplasms, Cellular Senescence, Senotherapeutics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 173 Literaturangaben. Gefördert von: Sichuan University West China Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor senescence is a durable cell-cycle arrest triggered by oncogenic signalling, DNA damage and therapeutic stress. Although senescence can restrain malignant expansion, heterogeneous senescence-associated secretory programs can also promote tumor progression, immune evasion and treatment resistance. Crucially, the composition, magnitude and persistence of these secretory programs vary across cell types, microenvironmental niches and treatment phases, making binary detection of "senescent cells" insufficient for deciding whether specific populations should be eliminated, modulated or preserved. This review synthesizes the molecular determinants of functional, temporal and spatial heterogeneity in tumor senescence and consolidates them into an operational state space to support phase-aware intervention logic. It further evaluates how artificial intelligence, combined with single-cell and spatial profiling, imaging and circulating readouts, can enable state-resolved mapping, stratification and monitoring of senescence contexts, thereby generating testable therapeutic window hypotheses and guiding the development of staged precision senotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCellular SenescenceSenotherapeuticsHumansAnimalsSenescence-Associated Secretory PhenotypeArtificial Intelligence

Stichwörter der Autor:innen

Artificial intelligenceSenescence-associated secretory phenotype (SASP)SenotherapySpatiotemporal heterogeneityTumor senescence

Substanzen

Senotherapeutics

Autor:innen und Institutionen

  • Department of Biotherapy, West China Hospital and State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China; Sichuan Provincial Key Laboratory of Nuclear Physics and Medical Research, Sichuan University, Ch…

Förderung

  • Sichuan University West China Hospital

Zitieren

APA

Xu, Z., Guo, J., Liu, Z., Yu, J., Yuan, R., Min, Y., Wei, Z., & Peng, X. (2026). From binary senescence to state-resolved senotherapy in cancer: Therapeutic windows from heterogeneity. Ageing Research Reviews, 121, 103270. https://doi.org/10.1016/j.arr.2026.103270

Vancouver

Xu Z, Guo J, Liu Z, Yu J, Yuan R, Min Y, et al. From binary senescence to state-resolved senotherapy in cancer: Therapeutic windows from heterogeneity. Ageing Research Reviews. 2026;121:103270. doi:10.1016/j.arr.2026.103270

BibTeX
@article{Xu2026,
  author = {Xu, Ziyu and Guo, Jiamin and Liu, Zheran and Yu, Jiayun and Yuan, Ruiwan and Min, Yu and Wei, Zhigong and Peng, Xingchen},
  title = {From binary senescence to state-resolved senotherapy in cancer: Therapeutic windows from heterogeneity},
  journal = {Ageing Research Reviews},
  year = {2026},
  volume = {121},
  pages = {103270},
  doi = {10.1016/j.arr.2026.103270}
}
Kostenlos starten →